Splicing: is there an alternative contribution to Parkinson’s disease?

作者: Valentina La Cognata , Velia D’Agata , Francesca Cavalcanti , Sebastiano Cavallaro

DOI: 10.1007/S10048-015-0449-X

关键词:

摘要: Alternative splicing is a crucial mechanism of gene expression regulation that enormously increases the coding potential our genome and represents an intermediate step between messenger RNA (mRNA) transcription protein posttranslational modifications. occupies central position in development functions nervous system. Therefore, its deregulation frequently leads to several neurological human disorders. In present review, we provide updated overview on impact alternative Parkinson’s disease (PD), second most common neurodegenerative disorder worldwide. We will describe major PD-linked genes by collecting current evidences about this intricate not carefully explored aspect. Assessing role PD pathobiology may represent toward improved understanding complex disease.

参考文章(140)
Olga Corti, Suzanne Lesage, Alexis Brice, What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease Physiological Reviews. ,vol. 91, pp. 1161- 1218 ,(2011) , 10.1152/PHYSREV.00022.2010
Olena Korvatska, Nicholas S. Strand, Jason D. Berndt, Tim Strovas, Dong-Hui Chen, James B. Leverenz, Konstantin Kiianitsa, Ignacio F. Mata, Emre Karakoc, J. Lynne Greenup, Emily Bonkowski, Joseph Chuang, Randall T. Moon, Evan E. Eichler, Deborah A. Nickerson, Cyrus P. Zabetian, Brian C. Kraemer, Thomas D. Bird, Wendy H. Raskind, Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS) Human Molecular Genetics. ,vol. 22, pp. 3259- 3268 ,(2013) , 10.1093/HMG/DDT180
Murat Kasap, Gurler Akpinar, Ali Sazci, Halil A. Idrisoglu, Haluk Vahaboğlu, Evidence for the presence of full-length PARK2 mRNA and Parkin protein in human blood. Neuroscience Letters. ,vol. 460, pp. 196- 200 ,(2009) , 10.1016/J.NEULET.2009.05.079
C. P. Zabetian, A. Samii, A. D. Mosley, J. W. Roberts, B. C. Leis, D. Yearout, W. H. Raskind, A. Griffith, A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations Neurology. ,vol. 65, pp. 741- 744 ,(2005) , 10.1212/01.WNL.0000172630.22804.73
Janet Ugolino, Shengyun Fang, Christian Kubisch, Mervyn J. Monteiro, Mutant Atp13a2 proteins involved in parkinsonism are degraded by ER-associated degradation and sensitize cells to ER-stress induced cell death Human Molecular Genetics. ,vol. 20, pp. 3565- 3577 ,(2011) , 10.1093/HMG/DDR274
Karen Nuytemans, Bram Meeus, David Crosiers, Nathalie Brouwers, Dirk Goossens, Sebastiaan Engelborghs, Philippe Pals, Barbara Pickut, Marleen Van den Broeck, Ellen Corsmit, Patrick Cras, Peter P. De Deyn, Jurgen Del-Favero, Christine Van Broeckhoven, Jessie Theuns, Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population. Human Mutation. ,vol. 30, pp. 1054- 1061 ,(2009) , 10.1002/HUMU.21007
Alessio Di Fonzo, Cristina Tassorelli, Michele De Mari, Hsin F Chien, Joaquim Ferreira, Christan F Rohé, Giulio Riboldazzi, Angelo Antonini, Gianni Albani, Alessandro Mauro, Roberto Marconi, Giovanni Abbruzzese, Leonardo Lopiano, Emiliana Fincati, Marco Guidi, Paolo Marini, Fabrizio Stocchi, Marco Onofrj, Vincenzo Toni, Michele Tinazzi, Giovanni Fabbrini, Paolo Lamberti, Nicola Vanacore, Giuseppe Meco, Petra Leitner, Ryan J Uitti, Zbigniew K Wszolek, Thomas Gasser, Erik J Simons, Guido J Breedveld, Stefano Goldwurm, Gianni Pezzoli, Cristina Sampaio, Egberto Barbosa, Emilia Martignoni, Ben A Oostra, Vincenzo Bonifati, None, Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease European Journal of Human Genetics. ,vol. 14, pp. 322- 331 ,(2006) , 10.1038/SJ.EJHG.5201539
Thomas A. Cooper, Lili Wan, Gideon Dreyfuss, RNA and Disease Cell. ,vol. 136, pp. 777- 793 ,(2009) , 10.1016/J.CELL.2009.02.011